From Nasdaq, Inc.:

1. Gilead Sciences has faced financial challenges due to declining revenue from its COVID-19 therapy, Veklury, and other clinical and regulatory issues. However, the company’s HIV franchise, oncology portfolio, and pipeline point to future growth. Gilead Sciences has maintained a steady dividend, offering a 3.9% yield with a cash payout ratio of around 48%. With a forward P/E ratio of 10.7, the stock looks attractive to income seekers.

2. EBay’s revenue has seen a modest 5% increase, but the company is focusing on high-value items and growing its advertising revenue. EBay’s dividend yield is 2.4%, with a cash payout ratio of 20.7%, and a forward P/E of 9.5. Although not a top growth stock, eBay remains a reliable dividend payer for low-risk, income-seeking investors.



Read more: 2 Beaten-Down Dividend Stocks to Buy Hand Over Fist